QT Sense was present at the European Association for Cancer Research (EACR) conference 2025. We showcased Quantum Nuova’s capabilities and how quantum sensing technologies can accelerate cancer detection using free radicals as biomarkers. We talked and connected with global leaders in oncology exploring how our cutting-edge solutions could help them uncover molecular signatures with unprecedented sensitivity.
Biomarker research continuously pushes the boundaries of what’s possible in oncology. By providing objective, measurable insights into disease, these powerful tools enhance our understanding, improve diagnostics and drug potency test, additionally lead to more effective treatments and better patient outcomes. The EACR 2025 Congress was undoubtedly showcase the latest breakthroughs and foster the collaborations needed to further unlock the immense potential of biomarkers in the fight against cancer.
📅 Date: 16–19 June 2025
📍 Location: Lisbon, Portugal.
